From dopamine to salience to psychosis--linking biology, pharmacology and phenomenology of psychosis.
about
The dopamine hypothesis of schizophrenia: version III--the final common pathwayZuclopenthixol versus placebo for schizophreniaPsychosocial interventions for people with both severe mental illness and substance misuseZuclopenthixol versus placebo for schizophreniaThe GABA B receptor agonist CGP44532 and the positive modulator GS39783 reverse some behavioural changes related to positive syndromes of psychosis in mice.High-potency cannabis and the risk of psychosisAntipsychotic-induced sensitization and tolerance: Behavioral characteristics, developmental impacts, and neurobiological mechanismsThe role of sleep dysfunction in the occurrence of delusions and hallucinations: A systematic reviewThe computational psychiatry of reward: broken brains or misguided minds?Translating the MAM model of psychosis to humansMetabolic alterations associated with schizophrenia: a critical evaluation of proton magnetic resonance spectroscopy studiesCharacterizing thalamo-cortical disturbances in schizophrenia and bipolar illnessAttachment, Neurobiology, and Mentalizing along the Psychosis ContinuumDrug models of schizophreniaA unified framework for addiction: vulnerabilities in the decision processPhenothiazine-derived antipsychotic drugs inhibit dynamin and clathrin-mediated endocytosis.Antipsychotic drugs on maternal behavior in rats.Symptom dimensions are associated with reward processing in unmedicated persons at risk for psychosis.Affect modulated startle in schizophrenia: subjective experience matters.D-amphetamine and antipsychotic drug effects on latent inhibition in mice lacking dopamine D2 receptors.Sex-dependent antipsychotic capacity of 17β-estradiol in the latent inhibition model: a typical antipsychotic drug in both sexes, atypical antipsychotic drug in males.Contrasting effects of increased and decreased dopamine transmission on latent inhibition in ovariectomized rats and their modulation by 17beta-estradiol: an animal model of menopausal psychosis?Cognitive rehabilitation for schizophrenia and the putative role of motivation and expectanciesDistinguishing familiarity-based from source-based memory performance in patients with schizophrenia.The default-mode, ego-functions and free-energy: a neurobiological account of Freudian ideas.A sex- and region-specific role of Akt1 in the modulation of methamphetamine-induced hyperlocomotion and striatal neuronal activity: implications in schizophrenia and methamphetamine-induced psychosisGray matter volumetric abnormalities associated with the onset of psychosis.Neuropsychopharmacology of auditory hallucinations: insights from pharmacological functional MRI and perspectives for future research.How frequent is chronic multiyear delusional activity and recovery in schizophrenia: a 20-year multi-follow-upDopamine and psychosis: theory, pathomechanisms and intermediate phenotypesAssociations between DRDs and schizophrenia in a Korean population: multi-stage association analysesIncreased mortality in schizophrenia due to cardiovascular disease - a non-systematic review of epidemiology, possible causes, and interventions.Working memory contributions to reinforcement learning impairments in schizophreniaQuantitative systems pharmacology as an extension of PK/PD modeling in CNS research and development.Would a rose, by any other name, smell sweeter?Probabilistic learning and inference in schizophrenia.Inferring reward prediction errors in patients with schizophrenia: a dynamic reward task for reinforcement learningPotentiation of latent inhibition by haloperidol and clozapine is attenuated in Dopamine D2 receptor (Drd-2)-deficient mice: do antipsychotics influence learning to ignore irrelevant stimuli via both Drd-2 and non-Drd-2 mechanisms?Using Mendelian randomisation to infer causality in depression and anxiety research.Changing the name of schizophrenia: patient perspectives and implications for DSM-V.
P2860
Q22242827-C89E98C5-E1C2-46F6-B64D-B3B26119C028Q24187287-0FC96B12-98CD-4D7D-AC14-ECF0725F4A73Q24197576-2BB95784-D1E0-4421-A684-43E8DD13D25EQ24202456-D1BF403A-ECA9-4FD4-A379-7A0339F507C5Q24596842-350FFB8E-1E14-45BE-A941-E86BF89240ECQ24651025-9E19A041-646E-4E48-86C5-BCDD9EDDD1BEQ26745506-16ECA904-8DC0-440D-B116-BC76F610400BQ26781048-9794091F-889F-4CC0-9031-60F63D0EF877Q26781582-02ADDEDF-7B42-4614-9416-966AFC3762C9Q26860217-03DA2D72-B89C-45BE-9BC6-288610384835Q26865740-E72E456D-729F-4057-92F1-BC375D162681Q27303206-0602A325-C69C-4F04-B278-0549F6BB71A6Q28069770-0D9A60CE-FAA1-4FE0-A368-796A5FC84873Q28084198-4AD234B5-3A8A-479A-9807-138207543059Q28680729-FC3C9657-E072-4E04-979D-FDDA9124D354Q30009226-0E8B07C7-9555-4049-849E-1572B56C16E3Q30375083-9BC0A9C3-FC7E-47A9-BB55-98F07C45BE80Q30390106-C3157304-59FA-48A7-94AE-103B32E3F854Q30396218-312E28DD-AED5-443F-8364-B74545A9A4C1Q30453020-D2447836-92A7-4141-8D54-CB7357550E32Q30474007-B3D62075-ED8C-4B5B-9F3F-B1EDA93E13F9Q30475350-BA6F6E63-4739-4079-AB17-0A14DCB0E0A6Q30491334-A9410071-1319-474A-8F7C-D7783BB0B1A1Q30491586-FFCF24A0-7104-451D-9B03-E8421CC7731DQ30493971-FE89FBD4-6B6B-46CF-BD17-1E9A88B04F5DQ30572456-1DC4364D-190E-4006-BBFE-6EABE69C1470Q30580970-8C3FEBAB-6048-42CC-B3E6-EC5F8834E12AQ30582343-3F3B64E9-EED4-4279-99CB-D567BE53A2ABQ33566091-53C4EBD6-EB49-4E6E-A84E-D47BB1BBD469Q33729433-2D99B151-7A80-402C-A882-B792E19032E4Q33778087-FB3F0822-479B-4E98-876D-BDDF06394D6AQ34248044-6AE34FDE-DD9B-4BCF-AB5D-F4AA51E6F6C8Q34303262-4ABD4DB6-9C94-4462-989E-31BFD076D436Q34323711-F59B0761-409C-437B-A673-9C90D20B4754Q34351049-CD65070E-F338-4435-96B7-A41C12D4997AQ34432407-7ADA6C28-AB1C-475B-A4DF-A86ED1386008Q34488198-F081FD1F-0C29-4FA1-B4A4-1E059BB760A6Q34505456-A96FC4C5-EA65-4C55-961D-C6F77A863B85Q34531808-6ECD047F-F204-4B5A-B5FC-0C1CB99698D6Q34606440-C9A2836F-6AAA-4017-B98B-A6314C15E0AB
P2860
From dopamine to salience to psychosis--linking biology, pharmacology and phenomenology of psychosis.
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
From dopamine to salience to p ...... nd phenomenology of psychosis.
@ast
From dopamine to salience to p ...... nd phenomenology of psychosis.
@en
From dopamine to salience to p ...... nd phenomenology of psychosis.
@nl
type
label
From dopamine to salience to p ...... nd phenomenology of psychosis.
@ast
From dopamine to salience to p ...... nd phenomenology of psychosis.
@en
From dopamine to salience to p ...... nd phenomenology of psychosis.
@nl
prefLabel
From dopamine to salience to p ...... nd phenomenology of psychosis.
@ast
From dopamine to salience to p ...... nd phenomenology of psychosis.
@en
From dopamine to salience to p ...... nd phenomenology of psychosis.
@nl
P921
P1476
From dopamine to salience to p ...... and phenomenology of psychosis
@en
P2093
P356
10.1016/J.SCHRES.2005.01.003
P407
P577
2005-11-01T00:00:00Z